The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011
Open accessAbstract
IMPORTANCE: Previous data on septal myectomy (SM) and alcohol septal ablation (ASA) in obstructive hypertrophic cardiomyopathy have been limited to small, nonrandomized, single-center studies. Use of septal reduction therapy and the effect of institutional experience on procedural outcomes nationally are unknown. OBJECTIVE: To examine in-hospital outcomes after SM and ASA stratified by hospital volume within a large, national inpatient database. DESIGN, SETTING, AND PARTICIPANTS: This study analyzed all patients who were hospitalized for SM or ASA in a nationwide inpatient database from January 1, 2003, through December 31, 2011. MAIN OUTCOMES AND MEASURES: Rates of adverse in-hospital events (death, stroke, bleeding, acute renal failure, and need for permanent pacemaker) were examined. Multivariate logistic regression analysis was performed to compare overall outcomes after each procedure based on tertiles of hospital volume of SM and ASA. RESULTS: Of 71 888 761 discharge records reviewed, a total of 11 248 patients underwent septal reduction procedures, of whom 6386 (56.8%) underwent SM and 4862 (43.2%) underwent ASA. A total of 59.9% of institutions performed 10 SM procedures or fewer, whereas 66.9% of institutions performed 10 ASA procedures or fewer during the study period. Incidence of in-hospital death (15.6%, 9.6%, and 3.8%; P < .001), need for permanent pacemaker (10.0%, 13.8%, and 8.9%; P < .001), and bleeding complications (3.3%, 3.8%, and 1.7%; P < .001) after SM was lower in higher-volume centers when stratified by first, second, and third tertiles of hospital volume, respectively. Similarly, there was a lower incidence of death (2.3%, 0.8%, and 0.6%; P = .02) and acute renal failure (6.2%, 7.6%, and 2.4%; P < .001) after ASA in higher-volume centers. The lowest tertile of SM volume among hospitals was an independent predictor of in-hospital all-cause mortality (adjusted odds ratio, 3.11; 95% CI, 1.98-4.89) and bleeding (adjusted odds ratio, 3.77; 95% CI, 2.12-6.70), whereas being in the lowest tertile of ASA by volume was not independently associated with an increased risk of adverse postprocedural events. CONCLUSIONS AND RELEVANCE: In US hospitals from 2003 through 2011, most centers that provide septal reduction therapy performed few SM and ASA procedures, which is below the threshold recommended by the 2011 American College of Cardiology Foundation/American Heart Association Task Force Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy. Low SM volume was associated with worse outcomes, including higher mortality, longer length of stay, and higher costs. More efforts are needed to encourage referral of patients to centers of excellence for septal reduction therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comorbidity measures for use with administrative data.
Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998) · Medical Care · doi:10.1097/00005650-199801000-00004 · Cited by 9,921
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T. T., & Bild, D. E. (1995) · Circulation · doi:10.1161/01.cir.92.4.785 · Cited by 2,275
Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., Ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,578
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Self-citationMaron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Ommen, S. R., Maron, B. J., Olivotto, I., Maron, M. S., Cecchi, F., Betocchi, S., Gersh, B. J., Ackerman, M. J., McCully, R. B., Dearani, J. A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.090 · Cited by 812
Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 804
Trends in Permanent Pacemaker Implantation in the United States From 1993 to 2009
Greenspon, A. J., Patel, J. D., Lau, E., Ochoa, J. A., Frisch, D. R., Ho, R. T., Pavri, B. B., & Kurtz, S. M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.017 · Cited by 478
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., Mahrholdt, H., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0212 · Cited by 341
Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Sorajja, P., Valeti, U., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., Hodge, D. O., Schaff, H. V., & Holmes, D. R. (2008) · Circulation · doi:10.1161/circulationaha.107.738740 · Cited by 310
Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Sorajja, P., Ommen, S. R., Holmes, D. R., Dearani, J. A., Rihal, C. S., Gersh, B. J., Lennon, R. J., & Nishimura, R. A. (2012) · Circulation · doi:10.1161/circulationaha.111.076257 · Cited by 292
Smedira, N. G., Lytle, B. W., Lever, H. M., Rajeswaran, J., Krishnaswamy, G., Kaple, R. K., Dolney, D. O. W., & Blackstone, E. H. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.07.063 · Cited by 271
Chikwe, J., Cavallaro, P., Itagaki, S., Seigerman, M., DiLuozzo, G., & Adams, D. H. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.02.039 · Cited by 267
Nagueh, S. F., Ommen, S. R., Lakkis, N. M., Killip, D., Zoghbi, W. A., Schaff, H. V., Danielson, G. K., Quiñones, M. A., Tajik, A. J., & Spencer, W. H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01614-x · Cited by 240
Procedural volume as a marker of quality for cabg surgery
Peterson, E. D., Coombs, L. P., Delong, E. R., Haan, C. K., & Ferguson, T. B. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.02.075 · Cited by 239
Minakata, K., Dearani, J. A., Nishimura, R. A., Maron, B. J., & Danielson, G. K. (2004) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.09.040 · Cited by 228
The case for surgery in obstructive hypertrophic cardiomyopathy
Maron, B. J., Dearani, J. A., Ommen, S. R., Maron, M. S., Schaff, H. V., Gersh, B. J., & Nishimura, R. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.063 · Cited by 220
Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy
Nagueh, S. F., Groves, B. M., Schwartz, L., Smith, K. M., Wang, A., Bach, R. G., Nielsen, C., Leya, F., Buergler, J. M., Rowe, S. K., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.073 · Cited by 204
Schoendube, F. A., Klues, H. G., Reith, S., Flachskampf, F. A., Hanrath, P., & Messmer, B. J. (1995) · Circulation · doi:10.1161/01.cir.92.9.122 · Cited by 199
Desai, M. Y., Bhonsale, A., Smedira, N. G., Naji, P., Thamilarasan, M., Lytle, B. W., & Lever, H. M. (2013) · Circulation · doi:10.1161/circulationaha.112.000849 · Cited by 193
Surgical management of hypertrophic obstructive cardiomyopathy
Heric, B., Lytle, B. W., Miller, D. P., Rosenkranz, E. R., Level, H. M., & Cosgrove, D. M. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(05)80026-1 · Cited by 180
Firoozi, S. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3285 · Cited by 177
Panaich, S., Badheka, A. O., Chothani, A., Mehta, K. D., Patel, N., Deshmukh, A. J., Singh, V., Savani, G. T., Arora, S., Patel, N., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.075 · Cited by 135
ten Berg, J. M., Suttorp, M.-J., Knaepen, P. J., Ernst, S. M., Vermeulen, F. E. E., & Jaarsma, W. (1994) · Circulation · doi:10.1161/01.cir.90.4.1781 · Cited by 121
Follow-Up of Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy
Fernandes, V. L. C., Nielsen, C. D., Nagueh, S. F., Herrin, A. E., Slifka, C., Franklin, J. L., & Spencer, W. H. (2008) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.07.005 · Cited by 111
A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy
Iacovoni, A., Spirito, P., Simon, C., Iascone, M. R., Dedda, G. D., Filippo, P. D., Pentiricci, S., Boni, L., Senni, M., Gavazzi, A., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs064 · Cited by 111
Ventricular Arrhythmia Following Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Noseworthy, P. A., Rosenberg, M. A., Fifer, M. A., Palacios, I. F., Lowry, P. A., Ruskin, J. N., Sanborn, D. M. Y., Picard, M. H., Vlahakes, G. J., Mela, T., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.02.056 · Cited by 98
Sorajja, P., Binder, J. S., Nishimura, R. A., Holmes, D. R., Rihal, C. S., Gersh, B. J., Bresnahan, J. F., & Ommen, S. R. (2012) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.24328 · Cited by 95
Shah, R. U., Henry, T. D., Rutten-Ramos, S. C., Garberich, R., Tighiouart, M., & Merz, C. N. B. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.07.017 · Cited by 79
Pettit, S., Jhund, P. S., Hawkins, N. M., Gardner, R. S., Haj‐Yahia, S., McMurray, J. J. V., & Petrie, M. C. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.966630 · Cited by 63
Veselka, J., Lawrenz, T., Stellbrink, C., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.04.027 · Cited by 39
Cited by
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Olivotto, I., Oreziak, A., Barriales-Villa, R., Abraham, T. P., Masri, A., Garcia-Pavia, P., Saberi, S., Lakdawala, N. K., Wheeler, M. T., Owens, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31792-x · Cited by 1,296
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.044 · Cited by 1,008
Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 994
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
Self-citation
Metadata
- Authors
- Kim, L. K., Swaminathan, R. V., Looser, P., Minutello, R. M., Wong, S. C., Bergman, G., Naidu, S. S., Gade, C. L. F., Charitakis, K., Singh, H. S., & Feldman, D. N.
- Venue
- JAMA Cardiology
- Publisher
- American Medical Association (AMA)
- Published
- 2016-06-01
- Volume
- 1
- Issue
- 3
- Pages
- 324
- ISSN
- 2380-6583 (ISSN-L)
- OpenAlex
- W2342438020
- Cited by
- 300
- References
- 32
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.